FDA approves 1st non-antipsychotic medication for agitation in Alzheimer’s disease
(NEW YORK) -- The Food and Drug Administration (FDA) approved the drug Auvelity this week for the treatment of agitation in adults with Alzheimer's dementia.The extended-release tablet is the first FDA-approved medication for this condition that is not an anti-psychotic.Anti-psychotics carry serious risks including stroke, sedation and increased death in older adults, according to the FDA. Having a non-antipsychotic option may be safer for patients, experts say."We've needed a drug like this for decades, […]
